Vertanical’s cannabis-based pain reliever, VER-01, has shown superiority over opioids in a Phase III trial.

ArriTech today announced the next generation of QGen Online, its software platform that enables businesses to bu ...

These five stocks are underperforming the S&P 500 in 2025, but have what it takes to reward investors over the long term.

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, ...

Redotpay’s recent round drew participation from investors including Coinbase Ventures, Temasek’s Vertex Ventures and Galaxy ...

Jupiter Endovascular, Inc. announced that its Vertex catheter has received FDA 510(k) clearance for the insertion of endovasc ...

Flying Vertex, a startup having extensive expertise in delivering 3D architectural rendering services to clients located ...

Perplexity AI, on Thursday, announced that it has integrated the popular AI-powered photo editing tool Gemini 2.5 Flash Image ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...

Vertex Pharmaceuticals Incorporated just reported a robust Q2 with earnings per share of $4.52, surpassing estimates and signaling a strong upward trajectory. As the numbers rolled in, the company ...

LIVE Group Ltd. research and ratings by Barron's. View LGLTF revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year’s Lasker~DeBakey Clinical Medical ...